Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs

類似資料

• Gefitinib or erlotinib in previously treated non–small‐cell lung cancer patients: a cohort study in Taiwan
  著者:: Chang, Chia‐Hao, 等
  出版事項: (2017)
• Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction
  著者:: Wu, Shang-Gin, 等
  出版事項: (2011)
• Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
  著者:: Liang, Sheng-Kai, 等
  出版事項: (2021)
• Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
  著者:: Shang-Gin Wu, 等
  出版事項: (2017-07-01)
• Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
  著者:: Wu, Shang-Gin, 等
  出版事項: (2017)